Ikaros 5 Inhibitors
Chemical inhibitors of Ikaros 5 play a significant role in modulating its activity through various biochemical pathways. LY294002 and Wortmannin, both phosphatidylinositol 3-kinase (PI3K) inhibitors, function by obstructing the PI3K signaling route, which is crucial for AKT activation. The inhibition of PI3K prevents the activation of AKT, a kinase known to phosphorylate and potentially inactivate Ikaros 5, thus maintaining Ikaros 5 in an active state. Concurrently, the MEK1/2 inhibitors PD98059 and U0126 block the activation of ERK1/2, a kinase that is implicated in phosphorylating Ikaros 5, leading to its inactivation. By preventing this phosphorylation, these inhibitors support the preservation of Ikaros 5's active form. Similarly, the JNK inhibitor SP600125 can prevent JNK-mediated phosphorylation events that could contribute to the inactivation of Ikaros 5.
Further regulating the activity of Ikaros 5, SB203580 specifically inhibits p38 MAP kinase, which is involved in phosphorylating substrates that regulate transcription factors like Ikaros 5. The inhibition of p38 MAP kinase by SB203580 can reduce the phosphorylation of such substrates, thus helping to sustain Ikaros 5's functionality. Rapamycin, by inhibiting mTOR complex 1, can prevent the translation of proteins that regulate Ikaros 5, thereby reducing its inactivation. Src family kinases, targeted by PP2, are another set of kinases that can phosphorylate Ikaros 5, and their inhibition by PP2 is another means to maintain the active state of Ikaros 5. Moreover, the protein kinase C (PKC) inhibitors Ro-31-8220 and Chelerythrine can reduce PKC-mediated phosphorylation events that could lead to Ikaros 5 inactivation. Lastly, KN-93, which inhibits Ca2+/calmodulin-dependent protein kinase II, and Staurosporine, a broad-spectrum kinase inhibitor, can both limit the phosphorylation of proteins that interact with or regulate Ikaros 5, thereby supporting the maintenance of its unphosphorylated, active form.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphatidylinositol 3-kinase (PI3K), which is involved in the activation of AKT. Since Ikaros 5 activity can be negatively regulated by AKT phosphorylation, inhibition of PI3K by LY294002 will prevent AKT activation, thereby maintaining Ikaros 5 in an active state. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is an inhibitor of the MEK1/2, the upstream kinase that activates ERK1/2. ERK1/2 has been implicated in the phosphorylation of Ikaros 5, which can lead to its functional inactivation. Inhibiting MEK1/2 with PD98059 would inhibit ERK1/2 activation, thus reducing phosphorylation of Ikaros 5 and preserving its function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which can phosphorylate substrates that may be involved in Ikaros 5 regulation. By inhibiting JNK, SP600125 can prevent downstream phosphorylation events that might contribute to Ikaros 5 inactivation. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a specific inhibitor of p38 MAP kinase. p38 MAP kinase can phosphorylate a variety of substrates that are involved in regulating transcription factors like Ikaros 5. Inhibition by SB203580 could reduce the phosphorylation of these substrates, thus preventing the functional inhibition of Ikaros 5. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another potent inhibitor of PI3K. By inhibiting PI3K, it prevents the formation of PIP3 and subsequent activation of AKT, leading to reduced phosphorylation and inactivation of Ikaros 5, thereby preserving its activity. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR complex 1 (mTORC1), which has been shown to control the translation of specific mRNAs encoding proteins that regulate Ikaros 5. By inhibiting mTORC1, Rapamycin could prevent the translation of these proteins, thus reducing the functional inhibition of Ikaros 5. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family kinases, which are involved in multiple signaling pathways that can phosphorylate and potentially inactivate Ikaros 5. By inhibiting Src kinases, PP2 could preserve the functional activity of Ikaros 5. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is an inhibitor of MEK1/2, similar to PD98059, and functions to block the activation of ERK1/2. By doing so, it would prevent the phosphorylation of Ikaros 5 by ERK1/2, thus inhibiting the functional inactivation of Ikaros 5. | ||||||
Ro 31-8220 | 138489-18-6 | sc-200619 sc-200619A | 1 mg 5 mg | $92.00 $245.00 | 17 | |
Ro-31-8220 is a potent protein kinase C (PKC) inhibitor. PKC isoforms can phosphorylate various proteins that modulate the function of transcription factors like Ikaros 5. Inhibition of PKC by Ro-31-8220 could therefore lead to reduced phosphorylation and inactivation of Ikaros 5. | ||||||
KN-93 | 139298-40-1 | sc-202199 | 1 mg | $182.00 | 25 | |
KN-93 is a selective inhibitor of Ca2+/calmodulin-dependent protein kinase II (CaMKII). CaMKII can influence the phosphorylation state of proteins involved in Ikaros 5 regulation. Inhibiting CaMKII with KN-93 could reduce phosphorylation-mediated functional inhibition of Ikaros 5. | ||||||